Windtree Announces Results from Its Phase 2 Study of Lucinactant for COVID-19
22 Mar 2022 //
GLOBENEWSWIRE
Windtree Completes Enrollment in Phase 2 Study of Lucinactant
01 Feb 2022 //
GLOBENEWSWIRE
Windtree Announces FDA Acceptance of IND Application for a Ph2 Trial
29 Sep 2020 //
INVESTORROOM